Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

Edwards Lifesciences Corporation (EW) had Consolidated Net Income/Loss of $380.70M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$1.65B
Net Income	$380.70M
Cost of Goods Sold	$362.60M
Gross Profit	$1.29B
Operating Expenses	$1.17B
Operating Income	$477.60M
Non-Operating Income/Expense	$-18.60M
Pre-Tax Income	$459.00M
Normalized Pre-Tax Income	$582.60M
Income after Taxes	$380.70M
Income from Continuous Operations	$380.70M
Consolidated Net Income/Loss	$380.70M
Normalized Income after Taxes	$525.38M
EBIT	$477.60M
EBITDA	$518.50M
Weighted-Average Shares Outstanding (Basic)	579.20M
Weighted-Average Shares Outstanding (Diluted)	580.70M
Earnings per Share (EPS) (Basic)	$0.66
Earnings per Share (EPS) (Diluted)	$0.66
Balance Sheet Financials
Current Assets	$6.23B
Property, Plant, and Equipment	$1.82B
Long-Term Assets	$7.09B
Total Assets	$13.32B
Current Liabilities	$1.41B
Long-Term Debt	$598.50M
Long-Term Liabilities	$1.58B
Total Liabilities	$2.99B
Common Equity	$10.33B
Tangible Shareholders Equity	$7.28B
Shareholders Equity	$10.33B
Common Shares Outstanding	577.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$43.80M
Cash Flow from Investing Activities	$-92.80M
Cash Flow from Financial Activities	$-451.20M
Beginning Cash	$2.94B
End Cash	$2.45B
Increase/Decrease in Cash	$-492.00M
Stock-Based Compensation	$45.40M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.42
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.05
Debt to Equity Ratio	0.06
Gross Margin	78.01%
Operating Margin	28.97%
EBIT Margin	28.97%
EBITDA Margin	--
Pre-Tax Profit Margin	27.84%
Profit Margin	23.09%
Free Cash Flow	$-21.10M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	0.32
Receiveable Turnover	1.69
Days Sales in Receivables	53.12
Return on Equity	3.69%
Return on Tangible Equity	5.23%
Return on Assets	2.86%
Return on Investments	3.48%
Book Value Per Share	$17.90
Free Cash Flow per Share	$-0.04
Operating Cash Flow per Share	$0.08

Data from Zacks Investment Research, Inc.